TerrAscend (OTCMKTS:TSNDF – Get Free Report) and Integer (NYSE:ITGR – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings and valuation.
Volatility & Risk
TerrAscend has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500. Comparatively, Integer has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.
Insider & Institutional Ownership
5.8% of TerrAscend shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 31.9% of TerrAscend shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares TerrAscend and Integer”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| TerrAscend | $260.56 million | 0.36 | -$81.33 million | ($0.09) | -3.34 |
| Integer | $1.85 billion | 2.33 | $102.81 million | $2.98 | 42.61 |
Integer has higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares TerrAscend and Integer’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TerrAscend | -28.96% | -30.76% | -4.89% |
| Integer | 5.68% | 11.84% | 5.98% |
Analyst Ratings
This is a summary of recent recommendations and price targets for TerrAscend and Integer, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| TerrAscend | 0 | 1 | 0 | 0 | 2.00 |
| Integer | 0 | 11 | 1 | 0 | 2.08 |
Integer has a consensus price target of $113.67, suggesting a potential downside of 10.49%. Given Integer’s stronger consensus rating and higher possible upside, analysts plainly believe Integer is more favorable than TerrAscend.
Summary
Integer beats TerrAscend on 12 of the 14 factors compared between the two stocks.
About TerrAscend
TerrAscend is a cannabis company that cultivates, processes and sells cannabis products through retail and wholesale channels. Its offerings include cannabis flower, pre-rolls, concentrates, edibles and other consumer products, sold under a portfolio of company and partner brands. The company operates in several U.S. markets, including Pennsylvania, New Jersey, Maryland, Michigan and California. Its retail business includes dispensaries operating under names such as The Apothecarium and Gage, alongside cultivation and processing facilities that supply its stores and other retailers.
About Integer
Integer Holdings Corporation develops and manufactures medical-device components and provides outsourced manufacturing services for medical technology companies. Its products are used in devices for cardiac rhythm management, neuromodulation, cardiovascular care, and other medical applications. The company’s offerings include batteries, capacitors, leads, catheters, and precision components, as well as engineered assemblies and manufacturing support. Integer serves medical-device original equipment manufacturers around the world.
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
